|Assessment Status||Rapid review complete|
|Brand||Oestrogel® Pump Gel|
|Indication||For: Hormone replacement therapy (HRT) for oestrogen deficiency symptoms in postmenopausal women; Prevention of osteoporosis in postmenopausal women at high risk of future fractures who are intolerant of, or contraindicated for, other medicinal products approved for the prevention of osteoporosis.|
|Rapid review commissioned||09/03/2020|
|Rapid review completed||09/04/2020|
|Rapid review outcome||A full HTA is not recommended. The NCPE recommends that Oestrogel® pump be considered for reimbursement*.|
*This recommendation should be considered while also having regard to the criteria specified in the Health (Pricing and Supply of Medical Goods Act) 2013
The HSE has approved reimbursement; August 2020.